Bruno Anglaret

2.2k total citations
31 papers, 762 citations indexed

About

Bruno Anglaret is a scholar working on Hematology, Pathology and Forensic Medicine and Oncology. According to data from OpenAlex, Bruno Anglaret has authored 31 papers receiving a total of 762 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Hematology, 10 papers in Pathology and Forensic Medicine and 10 papers in Oncology. Recurrent topics in Bruno Anglaret's work include Acute Myeloid Leukemia Research (10 papers), Lymphoma Diagnosis and Treatment (10 papers) and Multiple Myeloma Research and Treatments (7 papers). Bruno Anglaret is often cited by papers focused on Acute Myeloid Leukemia Research (10 papers), Lymphoma Diagnosis and Treatment (10 papers) and Multiple Myeloma Research and Treatments (7 papers). Bruno Anglaret collaborates with scholars based in France, United States and Switzerland. Bruno Anglaret's co-authors include Xavier Thomas, E Archimbaud, Anne Thiébaut, Thierry Façon, B. Grosbois, Jean‐Luc Harousseau, Pierre Biron, Christian Berthou, A.M. Peny and Jean‐Yves Blay and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Bruno Anglaret

30 papers receiving 749 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Bruno Anglaret France	13	394	302	241	187	150	31	762
Paule‐Marie Carli France	13	274 0.7×	376 1.2×	223 0.9×	223 1.2×	225 1.5×	29	822
Nicole Straetmans Belgium	17	572 1.5×	272 0.9×	546 2.3×	183 1.0×	333 2.2×	44	1.1k
H. Köppler Germany	19	382 1.0×	211 0.7×	297 1.2×	104 0.6×	283 1.9×	66	872
Jorge A. Spinolo United States	11	436 1.1×	379 1.3×	109 0.5×	150 0.8×	90 0.6×	18	794
W.Y. Au China	18	448 1.1×	328 1.1×	534 2.2×	148 0.8×	230 1.5×	57	1.1k
David Topolsky United States	15	348 0.9×	337 1.1×	141 0.6×	83 0.4×	93 0.6×	39	884
Marie‐Christiane Vekemans Belgium	14	195 0.5×	456 1.5×	112 0.5×	255 1.4×	169 1.1×	40	838
Taner Demirer Türkiye	11	493 1.3×	689 2.3×	118 0.5×	74 0.4×	132 0.9×	22	976
Éliane Duchayne France	18	241 0.6×	701 2.3×	356 1.5×	312 1.7×	470 3.1×	38	1.2k
Hassan El‐Solh Saudi Arabia	15	226 0.6×	169 0.6×	164 0.7×	261 1.4×	97 0.6×	40	693

Countries citing papers authored by Bruno Anglaret

Since Specialization

Citations

This map shows the geographic impact of Bruno Anglaret's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bruno Anglaret with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bruno Anglaret more than expected).

Fields of papers citing papers by Bruno Anglaret

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bruno Anglaret. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bruno Anglaret. The network helps show where Bruno Anglaret may publish in the future.

Co-authorship network of co-authors of Bruno Anglaret

This figure shows the co-authorship network connecting the top 25 collaborators of Bruno Anglaret. A scholar is included among the top collaborators of Bruno Anglaret based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bruno Anglaret. Bruno Anglaret is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Belhabri, Amine, Yves Bertrand, Catherine Sebban, et al.. (2019). Pattern of Care and Outcomes of Adolescent and Young Adults with Lymphoma Treated in the Rhône-Alpes Region. Journal of Adolescent and Young Adult Oncology. 8(6). 684–696.

Gyan, Emmanuel, Anne Sonet, Pauline Brice, et al.. (2018). Bendamustine and rituximab in elderly patients with low‐tumour burden follicular lymphoma. Results of the LYSA phase II BRIEF study. British Journal of Haematology. 183(1). 76–86. 11 indexed citations

Kottler, D., et al.. (2016). Remission of a long-lasting sarcoidosis after allogeneic hematopoietic stem cell transplantation for acute myeloid leukemia. JAAD Case Reports. 2(5). 408–410. 2 indexed citations

Zagadailov, Erin, et al.. (2013). Transplant Coordinators' Perceived Impact of Availability of Multiple Generic Immunosuppression Therapies on Patients, Workload, and Posttransplant Maintenance Therapy. SHILAP Revista de lepidopterología. 2013. 1–7. 3 indexed citations

Leblond, Véronique, Sylvie Chevret, Xavier Leleu, et al.. (2013). Phase II Trial In Advanced Waldenstrom Macroglobulinemia (WM) Patients With Bortezomib: Interest Of Addition Of Dexamethasone To Bortezomib On Behalf Of The French CLL/WM Intergroup (NCT 00777738). Blood. 122(21). 4359–4359. 2 indexed citations

Ketterer, Nicolas, Catherine Thiéblemont, Christophe Fermé, et al.. (2012). Phase III study of ACVBP versus ACVBP plus rituximab for patients with localized low-risk diffuse large B-cell lymphoma (LNH03-1B). Annals of Oncology. 24(4). 1032–1037. 21 indexed citations

Rodon, Philippe, Cyrille Hulin, Brigitte Pegourié, et al.. (2012). Bendamustine, Bortezomib and Dexamethasone (BVD) in Elderly Patients with Multiple Myeloma in First Relapse: Updated Results of the Intergroupe Francophone Du Myelome (IFM) 2009-01 Trial. Blood. 120(21). 4044–4044. 5 indexed citations

Fitoussi, Olivier, Karim Belhadj, Nicolas Mounier, et al.. (2011). Survival impact of rituximab combined with ACVBP and upfront consolidation autotransplantation in high-risk diffuse large B-cell lymphoma for GELA. Haematologica. 96(8). 1136–1143. 54 indexed citations

Ray‐Coquard, Isabelle, Sophie Dussart, Didier Mayeur, et al.. (2009). A risk model for severe anemia to select cancer patients for primary prophylaxis with epoetin α: a prospective randomized controlled trial of the ELYPSE study group. Annals of Oncology. 20(6). 1105–1112. 18 indexed citations

10.

Le, Quoc‐Hung, Youcef Chelghoum, Mohamed Elhamri, et al.. (2008). Prognostic Index for Older Adult Patients with Newly Diagnosed Acute Myeloid Leukemia: The Edouard Herriot Hospital Experience. 2(3). 198–204. 9 indexed citations

11.

Le, Quoc‐Hung, Youcef Chelghoum, Mohamed Elhamri, et al.. (2007). Prognostic Index for Older Adult Patients with Newly Diagnosed Acute Myeloid Leukemia: The Edouard Herriot Hospital Experience.. Blood. 110(11). 4352–4352. 2 indexed citations

12.

Façon, Thierry, Jean‐Luc Harousseau, F. Huguet, et al.. (2006). Superiority of melphalan-prednisone (MP) + thalidomide (THAL) over MP and autologous stem cell transplantation in the treatment of newly diagnosed elderly patients with multiple myeloma. Journal of Clinical Oncology. 24(18_suppl). 1–1. 148 indexed citations

13.

Belhabri, Amine, Xavier Thomas, Eric Wattel, et al.. (2002). All trans retinoic acid in combination with intermediate-dose cytarabine and idarubicin in patients with relapsed or refractory non promyelocytic acute myeloid leukemia: a phase II randomized trial. The Hematology Journal. 3(1). 49–55. 28 indexed citations

14.

Thiébaut, Anne, et al.. (2000). Impact of pre-induction therapy leukapheresis on treatment outcome in adult acute myelogenous leukemia presenting with hyperleukocytosis. Annals of Hematology. 79(9). 501–506. 69 indexed citations

15.

Thomas, Xavier, Bruno Anglaret, Jean‐Pierre Magaud, Joshua Epstein, & E Archimbaud. (1998). Interdependence between Cytokines and Cell Adhesion Molecules to Induce Interleukin-6 Production by Stromal Cells in Myeloma. Leukemia & lymphoma. 32(1-2). 107–119. 34 indexed citations

16.

Thomas, Xavier, et al.. (1998). Differential adhesiveness between blood and marrow leukemic cells having similar pattern of VLA adhesion molecule expression. Leukemia Research. 22(10). 953–960. 13 indexed citations

17.

Brice, Pauline, Réda Bouabdallah, Philippe Moreau, et al.. (1997). Prognostic factors for survival after high-dose therapy and autologous stem cell transplantation for patients with relapsing Hodgkin’s disease: analysis of 280 patients from the French registry. Bone Marrow Transplantation. 20(1). 21–26. 112 indexed citations

18.

Thomas, Xavier, Bruno Anglaret, Anne Thiébaut, et al.. (1997). Improvement of prognosis in refractory and relapsed acute promyelocytic leukemia over recent years: the role of all- trans retinoic acid therapy. Annals of Hematology. 75(5-6). 195–200. 13 indexed citations

19.

Thomas, Xavier, et al.. (1996). Occurrence of T-cell lymphoma in a patient with acute myelogenous leukemia. Annals of Hematology. 73(2). 95–98. 2 indexed citations

20.

Archimbaud, E, Bruno Anglaret, Xavier Thomas, et al.. (1992). Maintenance with low-dose cytarabine for acute myeloid leukemia in complete remission. Annals of Hematology. 65(2). 71–74. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact